Genetics Genetic Engineering Genetics Genetic Engineering Endangered Species Biotechnology Ethics Clinical Trials Animal Welfare Biodiversity Gene Editing
Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.